Redeye updates on Invisio after Q4-results which was much stronger than expected.
Redeye returns with an update following a softer-than-expected Q4 report.
The most interesting aspect of the Q4 2025 earnings release came on 29 January, when Scanfil publish...
Adjusted EBITA was slightly weaker than we expected in Q4.
* Q4 Paper EBIT of ~PLN 25m * Lower wood costs ahead, but markets still soft * Fair value range of S...
* Q4e: Sales of EUR 37m (45m), EBIT of EUR 0.7m (3.
Cell Impact avslutade 2025 med låg omsättning och ett fortsatt negativt rörelseresultat i en svag vä...
Redeye comments on Mendus’ Q4 report. We have updated our valuation scenarios and present a new base...
Aspo’s EUR 8.9m Q4 comparable EBITA landed clearly below our EUR 12.
Redeye returns with an update following Alligator Bioscience’s Q4 earnings release.
ByggPartner Gruppen avslutade 2025 starkt med 13 procent omsättningstillväxt och 74 procent högre or...
* Substantial margin-driven EBITA beat * We raise EBITA by 6-5% for '26e-'27e * Balance sheet soon s...
Redeye comments on Nitro Games Q4-results which where stronger-than-expected, driven by solid profit...
* Lower sales than estimated in Q4 * The CEO is optimistic for 2026 after a difficult 2025 * Adjustm...
* Q4 sales of SEK 18m (ABGSCe 16m), EBIT -3.3m (ABGSCe -10m) * Momentum in SOFC coatings for data ce...
* Solid end to the year * AY'25/26e guidance seems fine * Fair value range of NOK 18-25 Solid end t...
CDON delivered a strong fourth quarter with accelerating momentum across key operational metrics.
* Strong international growth offset by the Nordics * Short-term Pricer headwind * Fair value range ...
Relais' Q4 was soft, with the top line and adjusted EBITA below LSEG Data & Analytics consensus.
Redeye cuts its base case to SEK10 (from SEK11) and bull case to SEK15 (from SEK17), trimming 2026 n...
